IBDEI0OI ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11012,2)
;;=^5003413
;;^UTILITY(U,$J,358.3,11013,0)
;;=F18.188^^42^498^12
;;^UTILITY(U,$J,358.3,11013,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11013,1,3,0)
;;=3^Inhalant Induced Mild Neurocog Disorder w/ Mild Use Disorder
;;^UTILITY(U,$J,358.3,11013,1,4,0)
;;=4^F18.188
;;^UTILITY(U,$J,358.3,11013,2)
;;=^5003390
;;^UTILITY(U,$J,358.3,11014,0)
;;=F18.288^^42^498^13
;;^UTILITY(U,$J,358.3,11014,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11014,1,3,0)
;;=3^Inhalant Induced Mild Neurocog Disorder w/ Mod/Severe Use Disorder
;;^UTILITY(U,$J,358.3,11014,1,4,0)
;;=4^F18.288
;;^UTILITY(U,$J,358.3,11014,2)
;;=^5003403
;;^UTILITY(U,$J,358.3,11015,0)
;;=F18.988^^42^498^14
;;^UTILITY(U,$J,358.3,11015,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11015,1,3,0)
;;=3^Inhalant Induced Mild Neurocog Disorder w/o Use Disorder
;;^UTILITY(U,$J,358.3,11015,1,4,0)
;;=4^F18.988
;;^UTILITY(U,$J,358.3,11015,2)
;;=^5003415
;;^UTILITY(U,$J,358.3,11016,0)
;;=F18.159^^42^498^15
;;^UTILITY(U,$J,358.3,11016,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11016,1,3,0)
;;=3^Inhalant Induced Psychotic Disorder w/ Mild Use Disorder
;;^UTILITY(U,$J,358.3,11016,1,4,0)
;;=4^F18.159
;;^UTILITY(U,$J,358.3,11016,2)
;;=^5003387
;;^UTILITY(U,$J,358.3,11017,0)
;;=F18.259^^42^498^16
;;^UTILITY(U,$J,358.3,11017,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11017,1,3,0)
;;=3^Inhalant Induced Psychotic Disorder w/ Mod/Severe Use Disorder
;;^UTILITY(U,$J,358.3,11017,1,4,0)
;;=4^F18.259
;;^UTILITY(U,$J,358.3,11017,2)
;;=^5003400
;;^UTILITY(U,$J,358.3,11018,0)
;;=F18.959^^42^498^17
;;^UTILITY(U,$J,358.3,11018,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11018,1,3,0)
;;=3^Inhalant Induced Psychotic Disorder w/o Use Disorder
;;^UTILITY(U,$J,358.3,11018,1,4,0)
;;=4^F18.959
;;^UTILITY(U,$J,358.3,11018,2)
;;=^5003412
;;^UTILITY(U,$J,358.3,11019,0)
;;=F18.99^^42^498^24
;;^UTILITY(U,$J,358.3,11019,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11019,1,3,0)
;;=3^Inhalant Related Disorder,Unspec
;;^UTILITY(U,$J,358.3,11019,1,4,0)
;;=4^F18.99
;;^UTILITY(U,$J,358.3,11019,2)
;;=^5133360
;;^UTILITY(U,$J,358.3,11020,0)
;;=F18.11^^42^498^1
;;^UTILITY(U,$J,358.3,11020,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11020,1,3,0)
;;=3^Inhalant Abuse,In Remission
;;^UTILITY(U,$J,358.3,11020,1,4,0)
;;=4^F18.11
;;^UTILITY(U,$J,358.3,11020,2)
;;=^5151305
;;^UTILITY(U,$J,358.3,11021,0)
;;=Z00.6^^42^499^1
;;^UTILITY(U,$J,358.3,11021,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11021,1,3,0)
;;=3^Exam of Participant of Control in Clinical Research Program
;;^UTILITY(U,$J,358.3,11021,1,4,0)
;;=4^Z00.6
;;^UTILITY(U,$J,358.3,11021,2)
;;=^5062608
;;^UTILITY(U,$J,358.3,11022,0)
;;=F45.22^^42^500^1
;;^UTILITY(U,$J,358.3,11022,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11022,1,3,0)
;;=3^Body Dysmorphic Disorder
;;^UTILITY(U,$J,358.3,11022,1,4,0)
;;=4^F45.22
;;^UTILITY(U,$J,358.3,11022,2)
;;=^5003588
;;^UTILITY(U,$J,358.3,11023,0)
;;=F45.8^^42^500^16
;;^UTILITY(U,$J,358.3,11023,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11023,1,3,0)
;;=3^Somatoform Disorders,Other Specified
;;^UTILITY(U,$J,358.3,11023,1,4,0)
;;=4^F45.8
;;^UTILITY(U,$J,358.3,11023,2)
;;=^331915
;;^UTILITY(U,$J,358.3,11024,0)
;;=F45.0^^42^500^14
;;^UTILITY(U,$J,358.3,11024,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11024,1,3,0)
;;=3^Somatization Disorder
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0OI 3795 printed Apr 09, 2024@21:54:12 Page 2
IBDEI0OI ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11012,2)
+2 ;;=^5003413
+3 ;;^UTILITY(U,$J,358.3,11013,0)
+4 ;;=F18.188^^42^498^12
+5 ;;^UTILITY(U,$J,358.3,11013,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,11013,1,3,0)
+8 ;;=3^Inhalant Induced Mild Neurocog Disorder w/ Mild Use Disorder
+9 ;;^UTILITY(U,$J,358.3,11013,1,4,0)
+10 ;;=4^F18.188
+11 ;;^UTILITY(U,$J,358.3,11013,2)
+12 ;;=^5003390
+13 ;;^UTILITY(U,$J,358.3,11014,0)
+14 ;;=F18.288^^42^498^13
+15 ;;^UTILITY(U,$J,358.3,11014,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,11014,1,3,0)
+18 ;;=3^Inhalant Induced Mild Neurocog Disorder w/ Mod/Severe Use Disorder
+19 ;;^UTILITY(U,$J,358.3,11014,1,4,0)
+20 ;;=4^F18.288
+21 ;;^UTILITY(U,$J,358.3,11014,2)
+22 ;;=^5003403
+23 ;;^UTILITY(U,$J,358.3,11015,0)
+24 ;;=F18.988^^42^498^14
+25 ;;^UTILITY(U,$J,358.3,11015,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,11015,1,3,0)
+28 ;;=3^Inhalant Induced Mild Neurocog Disorder w/o Use Disorder
+29 ;;^UTILITY(U,$J,358.3,11015,1,4,0)
+30 ;;=4^F18.988
+31 ;;^UTILITY(U,$J,358.3,11015,2)
+32 ;;=^5003415
+33 ;;^UTILITY(U,$J,358.3,11016,0)
+34 ;;=F18.159^^42^498^15
+35 ;;^UTILITY(U,$J,358.3,11016,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,11016,1,3,0)
+38 ;;=3^Inhalant Induced Psychotic Disorder w/ Mild Use Disorder
+39 ;;^UTILITY(U,$J,358.3,11016,1,4,0)
+40 ;;=4^F18.159
+41 ;;^UTILITY(U,$J,358.3,11016,2)
+42 ;;=^5003387
+43 ;;^UTILITY(U,$J,358.3,11017,0)
+44 ;;=F18.259^^42^498^16
+45 ;;^UTILITY(U,$J,358.3,11017,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,11017,1,3,0)
+48 ;;=3^Inhalant Induced Psychotic Disorder w/ Mod/Severe Use Disorder
+49 ;;^UTILITY(U,$J,358.3,11017,1,4,0)
+50 ;;=4^F18.259
+51 ;;^UTILITY(U,$J,358.3,11017,2)
+52 ;;=^5003400
+53 ;;^UTILITY(U,$J,358.3,11018,0)
+54 ;;=F18.959^^42^498^17
+55 ;;^UTILITY(U,$J,358.3,11018,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,11018,1,3,0)
+58 ;;=3^Inhalant Induced Psychotic Disorder w/o Use Disorder
+59 ;;^UTILITY(U,$J,358.3,11018,1,4,0)
+60 ;;=4^F18.959
+61 ;;^UTILITY(U,$J,358.3,11018,2)
+62 ;;=^5003412
+63 ;;^UTILITY(U,$J,358.3,11019,0)
+64 ;;=F18.99^^42^498^24
+65 ;;^UTILITY(U,$J,358.3,11019,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,11019,1,3,0)
+68 ;;=3^Inhalant Related Disorder,Unspec
+69 ;;^UTILITY(U,$J,358.3,11019,1,4,0)
+70 ;;=4^F18.99
+71 ;;^UTILITY(U,$J,358.3,11019,2)
+72 ;;=^5133360
+73 ;;^UTILITY(U,$J,358.3,11020,0)
+74 ;;=F18.11^^42^498^1
+75 ;;^UTILITY(U,$J,358.3,11020,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,11020,1,3,0)
+78 ;;=3^Inhalant Abuse,In Remission
+79 ;;^UTILITY(U,$J,358.3,11020,1,4,0)
+80 ;;=4^F18.11
+81 ;;^UTILITY(U,$J,358.3,11020,2)
+82 ;;=^5151305
+83 ;;^UTILITY(U,$J,358.3,11021,0)
+84 ;;=Z00.6^^42^499^1
+85 ;;^UTILITY(U,$J,358.3,11021,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,11021,1,3,0)
+88 ;;=3^Exam of Participant of Control in Clinical Research Program
+89 ;;^UTILITY(U,$J,358.3,11021,1,4,0)
+90 ;;=4^Z00.6
+91 ;;^UTILITY(U,$J,358.3,11021,2)
+92 ;;=^5062608
+93 ;;^UTILITY(U,$J,358.3,11022,0)
+94 ;;=F45.22^^42^500^1
+95 ;;^UTILITY(U,$J,358.3,11022,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,11022,1,3,0)
+98 ;;=3^Body Dysmorphic Disorder
+99 ;;^UTILITY(U,$J,358.3,11022,1,4,0)
+100 ;;=4^F45.22
+101 ;;^UTILITY(U,$J,358.3,11022,2)
+102 ;;=^5003588
+103 ;;^UTILITY(U,$J,358.3,11023,0)
+104 ;;=F45.8^^42^500^16
+105 ;;^UTILITY(U,$J,358.3,11023,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,11023,1,3,0)
+108 ;;=3^Somatoform Disorders,Other Specified
+109 ;;^UTILITY(U,$J,358.3,11023,1,4,0)
+110 ;;=4^F45.8
+111 ;;^UTILITY(U,$J,358.3,11023,2)
+112 ;;=^331915
+113 ;;^UTILITY(U,$J,358.3,11024,0)
+114 ;;=F45.0^^42^500^14
+115 ;;^UTILITY(U,$J,358.3,11024,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,11024,1,3,0)
+118 ;;=3^Somatization Disorder
